Skip to main content
Premium Trial:

Request an Annual Quote

Genome, Jay; Jay, Genome

According to this article in Forbes, Jay Flatley told analysts at an investor conference, "We'd like to give all of you an opportunity to meet your genome." The article details some of Illumina's plans going forward, but it seems the real excitement was when Flatley revealed some details about Illumina's partnership with startup 23andMe. While 23andMe's business model is still unclear, it seems to be focused on genotyping for the consumer market -- a sector that Illumina predicts will be worth $1.5 billion in several years.


The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.